Pro Medicus Limited
PME
Kedudukan dalam Saham
#1628
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Harga Saham
$126.25
Modal Pasaran
$13.19B
Perubahan (1 hari)
-0.30%
Perubahan (1 tahun)
-32.46%
Negara
AU
Perdagangan Pro Medicus Limited (PME)
Kategori
Healthcare
Pendapatan untuk Pro Medicus Limited (PME)
Pendapatan pada Jun 2026 TTM: $266.26M
Menurut laporan kewangan terkini Pro Medicus Limited, pendapatan semasa syarikat ialah $266.26M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $77.79M, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $57.38M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Pro Medicus Limited dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $266.26M | 147.66% |
| 2025 | $107.51M | 38.21% |
| 2024 | $77.79M | 35.55% |
| 2023 | $57.38M | 31.89% |
| 2022 | $43.51M | 35.35% |
| 2021 | $32.15M | 55.19% |
| 2020 | $20.71M | 12.91% |
| 2019 | $18.35M | 61.89% |
| 2018 | $11.33M | 9.72% |
| 2017 | $10.33M | 45.98% |
| 2016 | $7.07M | 79.75% |
| 2015 | $3.94M | 70.17% |
| 2014 | $2.31M | -151.63% |
| 2013 | $-4.48M | -530.12% |
| 2012 | $1.04M | 38.76% |
| 2011 | $750.57K | -84.46% |
| 2010 | $4.83M | -24.83% |
| 2009 | $6.42M | -40.86% |
| 2008 | $10.86M | 31.35% |
| 2007 | $8.27M | 29.34% |
| 2006 | $6.39M | 9.18% |
| 2005 | $5.86M | 68.01% |
| 2004 | $3.49M | -19.23% |
| 2003 | $4.32M | 13.36% |
| 2002 | $3.81M | 19.88% |
| 2001 | $3.18M | 2.97% |
| 2000 | $3.08M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $2.04B | 667.30% |
US
|
|
| $295.53M | 11.00% |
US
|
|
| $-259.89M | -197.61% |
US
|
|
| $-74.89M | -128.13% |
US
|
|
| - | - |
US
|
